First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

BACKGROUND: First-line treatment strategies for programmed death-ligand 1 (PD-L1) negative non-small cell lung cancer (NSCLC) patients include chemotherapy and combination with anti-angiogenesis drugs and/or immune checkpoint inhibitor. We conducted a Bayesian network meta-analysis to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ling, Liang, Wen-Hua, Mu, De-Guang, Xu, Song, Hong, Shao-Dong, Stebbing, Justin, Liang, Fei, Xia, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261279/
https://www.ncbi.nlm.nih.gov/pubmed/34249693
http://dx.doi.org/10.3389/fonc.2021.657545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261279/
https://www.ncbi.nlm.nih.gov/pubmed/34249693
http://dx.doi.org/10.3389/fonc.2021.657545

Ejemplares similares